Radiation Therapy for Eye Cancer

Radiation therapy uses high-energy x-rays to kill cancer cells. It is a common treatment for eye melanoma. Radiation therapy can often save some vision in the eye. Sometimes vision might be lost if the radiation damages other parts of the eye. An advantage over surgery is that the eye structure is preserved, which can result in a better appearance after treatment.

Different types of radiation therapy can be used to treat eye cancers.

Brachytherapy (Plaque therapy)

In this form of radiation therapy, the doctor places small seeds of radioactive material directly into or very close to the cancer. The radiation from the seeds travels a very short distance, so most of it will be focused only on the tumor. This has become the most common radiation treatment for most eye melanomas. Studies have shown that in many cases it is as effective as surgery to remove the eye (enucleation).

An operation is needed to put the plaque (a small round piece of metal that holds the radioactive seeds) in place. This surgery usually takes 1 or 2 hours and can be done with local anesthetic (numbing medicine) and sedation. The plaque is usually kept there for 4 to 7 days, depending on the size of the tumor and the strength of the radiation source. You will probably remain in the hospital during this time. Another surgery to remove the plaque is then done. It usually takes less than an hour, and you will probably be able to go home the same day. The full effect of the radiation on the tumor is not seen for 3 to 6 months.

This treatment cures about 9 out of 10 small to medium size tumors and can preserve vision in some patients, depending on what part of the eye the melanoma is in. The outlook for vision is not as good if the tumor is very close to the optic nerve, which carries visual images from the eye to the brain.

External beam radiation therapy

In this approach, radiation from a source outside the body is focused on the cancer. For eye melanomas, the use of this type of radiation therapy is generally limited to newer methods that focus narrow beams of radiation on the tumor.

Proton beam radiation therapy: Instead of using x-rays as in standard radiation therapy, this approach aims proton beams toward the cancer. Unlike x-rays, which release energy both before and after they hit their target, protons cause little damage to tissues they pass through and release their energy only after traveling a certain distance. This means that proton beam radiation may be able to deliver more radiation to the tumor but do less damage to nearby normal tissues. This type of radiation treatment is used more often for larger tumors and for tumors that are closer to the optic nerve.

Getting treatment is much like getting an x-ray, but the dose of radiation is much higher. In most cases, the total dose of radiation is divided into daily fractions (usually given Monday thru Friday) over several weeks. The treatment is typically not painful.

The specialized machines needed to make protons are only found in certain centers in the United States at this time.

Stereotactic radiosurgery: Despite the name, there is no actual surgery involved in this treatment. The term "surgery" is used to describe the accurate nature of the radiation beams. This type of treatment delivers a large, precise radiation dose to the tumor area in a single session. It is not used as often as brachytherapy or proton beam therapy as the initial treatment for eye melanomas. Different machines can be used to deliver radiation in one of two ways:

  • A Gamma Knife stays in one place and focuses radiation beams from hundreds of different angles at the tumor all at once for a short period of time in one treatment session.
  • Several machines, such as CyberKnife® or Clinac® use a computer to control a radiation machine that moves in a circular motion (180 degrees) over the tumor to deliver individual radiation beams at separate times from many different angles. These treatments are done over multiple days.

Possible side effects of radiation therapy

The main concern with radiation therapy is damage to parts of the eye, leading to problems such as blurry vision, dry eye, cataracts, retinal detachment, glaucoma (increased pressure inside the eye), loss of eye lashes, problems with tear ducts, or bleeding into the eye. Some of these treatments can result in partial or complete loss of vision or other problems, which might not happen right away and may worsen with time. The risk depends on the size and location of the tumor.

Because the radiation is focused only on the affected eye, it is not likely to affect vision in the other eye or to cause other side effects sometimes linked with radiation therapy, such as hair loss or nausea.

More information about radiation therapy

To learn more about how radiation is used to treat cancer, see Radiation Therapy.

To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Brewington BY, Shao YF, Davidorf FH, Cebulla CM. Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions. Clinical Ophthalmology (Auckland, NZ). 2018;12:925-934. doi:10.2147/OPTH.S129645.

Finger PT. Chapter 116: Intraocular melanoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.

Grisanti S, Tura A. Uveal Melanoma. In Scott JF, Gerstenblith MR, eds. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Available from: https://www.ncbi.nlm.nih.gov/books/NBK506988/ doi: 10.15586/codon.noncutaneousmelanoma.2018.

Karcioglu ZA, Haik BG. Chapter 67: Eye, orbit, and adnexal structures. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.

National Cancer Institute. Physician Data Query (PDQ). Intraocular (Uveal) Melanoma Treatment. 2018. Accessed at https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq#link/_101_toc. Accessed August 24, 2018.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Uveal Melanoma. V.1.2018. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/uveal.pdf on August 15, 2018.

Last Medical Review: November 30, 2018 Last Revised: November 30, 2018

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.